# StemImmune, Inc – FDA Inspection, Aug 4, 2017

Source: https://www.keypedia.com/records/fda_inspections/stemimmune-inc/f1731990-3260-4d8b-8801-d383198c7075
Source feed: FDA_Inspections

> FDA inspection 1020495 of StemImmune, Inc, August 04, 2017. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020495
- Company Name: StemImmune, Inc
- Inspection Date: 2017-08-04
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/darla-j-christopher/64d3f47f-f3c0-4cfd-a3e8-4dc0e69d04bd)
- [Investigator](https://www.keypedia.com/people/michele-l-forster/5e4b6db7-412f-4e4f-87a9-8af15a16429f)

Company: https://www.keypedia.com/companies/stemimmune-inc/02c030e6-3e9a-4adf-a66f-44c46e9d9a64

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d